KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Total Liabilities (2016 - 2025)

Cardlytics (CDLX) has disclosed Total Liabilities for 10 consecutive years, with $292.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 9.47% year-over-year to $292.1 million, compared with a TTM value of $292.1 million through Dec 2025, down 9.47%, and an annual FY2025 reading of $292.1 million, down 9.47% over the prior year.
  • Total Liabilities was $292.1 million for Q4 2025 at Cardlytics, down from $297.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $573.1 million in Q4 2021 and bottomed at $278.1 million in Q1 2021.
  • Average Total Liabilities over 5 years is $407.9 million, with a median of $403.4 million recorded in 2023.
  • The sharpest move saw Total Liabilities skyrocketed 886.18% in 2021, then fell 26.55% in 2024.
  • Year by year, Total Liabilities stood at $573.1 million in 2021, then dropped by 16.31% to $479.6 million in 2022, then fell by 8.4% to $439.3 million in 2023, then dropped by 26.55% to $322.7 million in 2024, then decreased by 9.47% to $292.1 million in 2025.
  • Business Quant data shows Total Liabilities for CDLX at $292.1 million in Q4 2025, $297.5 million in Q3 2025, and $302.4 million in Q2 2025.